Biodesix Inc (BDSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -31,350 | -30,726 | N/A | N/A |
| Depreciation Amortization | 8,710 | 3,199 | N/A | N/A |
| Accounts receivable | -10,308 | -3,646 | N/A | N/A |
| Other Working Capital | -4,801 | -1,645 | N/A | N/A |
| Other Operating Activity | 16,383 | 11,092 | 0 | 0 |
| Operating Cash Flow | $-21,366 | $-21,726 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,945 | -1,310 | N/A | N/A |
| Net Acquisitions | -750 | -456 | N/A | N/A |
| Purchase Sale Intangibles | -232 | -106 | N/A | N/A |
| Other Investing Activity | -232 | -106 | 0 | 0 |
| Investing Cash Flow | $-2,927 | $-1,872 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 16,040 | 13,044 | N/A | N/A |
| Common Stock Issued | 73,340 | 47 | N/A | N/A |
| Other Financing Activity | -8,249 | 9,881 | 0 | 0 |
| Financing Cash Flow | $81,131 | $22,972 | $N/A | $N/A |
| Beginning Cash Position | 5,468 | 6,094 | N/A | N/A |
| End Cash Position | 62,306 | 5,468 | N/A | N/A |
| Net Cash Flow | $56,838 | $-626 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -21,366 | -21,726 | N/A | N/A |
| Capital Expenditure | -1,945 | -1,310 | N/A | N/A |
| Free Cash Flow | -23,311 | -23,036 | 0 | 0 |